최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기Cancer research and treatment : official journal of Korean Cancer Association, v.52 no.1, 2020년, pp.74 - 84
Bae, Jeong Mo (Department of Pathology, Seoul National University Hospital, Seoul National University College of Medicine) , Wen, Xianyu (Laboratory of Epigenetics, Cancer Research Institute, Seoul National University College of Medicine) , Kim, Tae-Shin (Laboratory of Epigenetics, Cancer Research Institute, Seoul National University College of Medicine) , Kwak, Yoonjin (Department of Pathology, Seoul National University Bundang Hospital, Seoul National University College of Medicine) , Cho, Nam-Yun (Laboratory of Epigenetics, Cancer Research Institute, Seoul National University College of Medicine) , Lee, Hye Seung (Department of Pathology, Seoul National University Bundang Hospital, Seoul National University College of Medicine) , Kang, Gyeong Hoon (Department of Pathology, Seoul National University Hospital, Seoul National University College of Medicine)
Purpose The purpose of this study was to reveal the clinicopathological characteristics and prognostic implications associated with fibroblast growth factor receptor 1 (FGFR1) amplification in colorectal cancers (CRCs). Materials and Methods We measured the copy number of FGFR1 by droplet digital po...
1 Siegel RL Miller KD Jemal A Cancer statistics, 2019 CA Cancer J Clin 2019 69 7 34 30620402
2 Jung KW Won YJ Kong HJ Lee ES Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2016 Cancer Res Treat 2019 51 417 30 30913865
3 Cancer Genome Atlas Network Comprehensive molecular characterization of human colon and rectal cancer Nature 2012 487 330 7 22810696
4 Fearon ER Vogelstein B A genetic model for colorectal tumorigenesis Cell 1990 61 759 67 2188735
5 Ciriello G Miller ML Aksoy BA Senbabaoglu Y Schultz N Sander C Emerging landscape of oncogenic signatures across human cancers Nat Genet 2013 45 1127 33 24071851
6 Dienstmann R Rodon J Prat A Perez-Garcia J Adamo B Felip E Genomic aberrations in the FGFR pathway: opportunities for targeted therapies in solid tumors Ann Oncol 2014 25 552 63 24265351
7 Kim HR Kim DJ Kang DR Lee JG Lim SM Lee CY Fibroblast growth factor receptor 1 gene amplification is associated with poor survival and cigarette smoking dosage in patients with resected squamous cell lung cancer J Clin Oncol 2013 31 731 7 23182986
8 Kim HS Lee SE Bae YS Kim DJ Lee CG Hur J Fibroblast growth factor receptor 1 gene amplification is associated with poor survival in patients with resected esophageal squamous cell carcinoma Oncotarget 2015 6 2562 72 25537505
9 Elbauomy Elsheikh S Green AR Lambros MB Turner NC Grainge MJ Powe D FGFR1 amplification in breast carcinomas: a chromogenic in situ hybridisation analysis Breast Cancer Res 2007 9 R23 17397528
10 Wolff AC Hammond ME Hicks DG Dowsett M McShane LM Allison KH Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline update J Clin Oncol 2013 31 3997 4013 24101045
11 Fritzsche FR Bode PK Moch H Kristiansen G Varga Z Bode B Determination of the Her-2/neu gene amplification status in cytologic breast cancer specimens using automated silverenhanced in-situ hybridization (SISH) Am J Surg Pathol 2010 34 1180 5 20661016
12 Yoo SB Lee HJ Park JO Choe G Chung DH Seo JW Reliability of chromogenic in situ hybridization for epidermal growth factor receptor gene copy number detection in nonsmall-cell lung carcinomas: a comparison with fluorescence in situ hybridization study Lung Cancer 2010 67 301 5 19505745
13 Huggett JF Cowen S Foy CA Considerations for digital PCR as an accurate molecular diagnostic tool Clin Chem 2015 61 79 88 25338683
14 Goke F Goke A von Massenhausen A Franzen A Sharma R Kirsten R Fibroblast growth factor receptor 1 as a putative therapy target in colorectal cancer Digestion 2013 88 172 81 24135816
15 Bae JM Kim JH Kwak Y Lee DW Cha Y Wen X Distinct clinical outcomes of two CIMP-positive colorectal cancer subtypes based on a revised CIMP classification system Br J Cancer 2017 116 1012 20 28278514
16 Kinugasa H Nouso K Tanaka T Miyahara K Morimoto Y Dohi C Droplet digital PCR measurement of HER2 in patients with gastric cancer Br J Cancer 2015 112 1652 5 25897674
17 Ribic CM Sargent DJ Moore MJ Thibodeau SN French AJ Goldberg RM Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer N Engl J Med 2003 349 247 57 12867608
18 Yao TJ Zhu JH Peng DF Cui Z Zhang C Lu PH AZD-4547 exerts potent cytostatic and cytotoxic activities against fibroblast growth factor receptor (FGFR)-expressing colorectal cancer cells Tumour Biol 2015 36 5641 8 25691251
19 Liu J Lichtenberg T Hoadley KA Poisson LM Lazar AJ Cherniack AD An integrated TCGA pan-cancer clinical data resource to drive high-quality survival outcome analytics Cell 2018 173 400 16 29625055
20 Liu Y Sethi NS Hinoue T Schneider BG Cherniack AD Sanchez-Vega F Comparative molecular analysis of gastrointestinal adenocarcinomas Cancer Cell 2018 33 721 35 29622466
21 Kwak Y Nam SK Seo AN Kim DW Kang SB Kim WH Fibroblast growth factor receptor 1 gene copy number and mRNA expression in primary colorectal cancer and its clinicopathologic correlation Pathobiology 2015 82 76 83 26088290
22 Turner N Pearson A Sharpe R Lambros M Geyer F Lopez-Garcia MA FGFR1 amplification drives endocrine therapy resistance and is a therapeutic target in breast cancer Cancer Res 2010 70 2085 94 20179196
23 Hindson BJ Ness KD Masquelier DA Belgrader P Heredia NJ Makarewicz AJ High-throughput droplet digital PCR system for absolute quantitation of DNA copy number Anal Chem 2011 83 8604 10 22035192
24 Zhu Y Lu D Lira ME Xu Q Du Y Xiong J Droplet digital polymerase chain reaction detection of HER2 amplification in formalin fixed paraffin embedded breast and gastric carcinoma samples Exp Mol Pathol 2016 100 287 93 26626802
25 Koole K Brunen D van Kempen PM Noorlag R de Bree R Lieftink C FGFR1 is a potential prognostic biomarker and therapeutic target in head and neck squamous cell carcinoma Clin Cancer Res 2016 22 3884 93 26936917
26 Yang X Han H De Carvalho DD Lay FD Jones PA Liang G Gene body methylation can alter gene expression and is a therapeutic target in cancer Cancer Cell 2014 26 577 90 25263941
27 Sato T Oshima T Yoshihara K Yamamoto N Yamada R Nagano Y Overexpression of the fibroblast growth factor receptor-1 gene correlates with liver metastasis in colorectal cancer Oncol Rep 2009 21 211 6 19082464
28 Shaw AT Hsu PP Awad MM Engelman JA Tyrosine kinase gene rearrangements in epithelial malignancies Nat Rev Cancer 2013 13 772 87 24132104
29 Paik PK Shen R Ferry D Soria JC Mathewson A Kilgour E A phase 1b open-label multicenter study of AZD4547 in patients with advanced squamous cell lung cancers: preliminary antitumor activity and pharmacodynamic data J Clin Oncol 2014 32 15 Suppl 8035
30 Weiss J Sos ML Seidel D Peifer M Zander T Heuckmann JM Frequent and focal FGFR1 amplification associates with therapeutically tractable FGFR1 dependency in squamous cell lung cancer Sci Transl Med 2010 2 62ra93
※ AI-Helper는 부적절한 답변을 할 수 있습니다.